Key result
Novel human T-cell cyclophilin hCyP33 uniquely combines RNA binding and protein folding.
Why the study?
Cyclophilins are known to bind cyclosporins and proteins, but a nuclear cyclophilin with RNA-binding capability in human T cells had not been described.
Population
Human T cells
Design
Molecular characterization study
Answers are grounded in this paper and cite their sources.
May link RNA regulation to protein folding in T cells; leaves open any role in cardiac immunology or immunosuppression.
Cyclophilins (CyPs) are binding proteins for the immunosuppressive drug cyclosporin A (CsA). CyPs are evolutionarily highly conserved proteins present in both pro- and eukaryotes as well as in different subcellular locations. CyPs possess enzymatic activity, namely peptidyl-prolyl cis-trans isomerase (PPIase) activity; CyPs are involved in cellular protein folding and protein interactions. To date, only cyclosporins and proteins are known to interact with CyPs. Here we describe a novel nuclear cyclophilin (hCyP33) from human T cells with an additional RNA-binding domain. This combines for the first time RNA binding and protein folding in one protein.
No takes yet. Share an insight, caveat, or question.
Mi et al. (1996) studied this question. A novel nuclear cyclophilin (hCyP33) with an RNA-binding domain was identified in human T cells, combining RNA binding and protein folding in one protein for the first time.
Synapse has enriched 10 related papers. Consider them for comparative context: